3dda

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 20: Line 20:
==About this Structure==
==About this Structure==
-
3DDA is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3DDA OCA].
+
3DDA is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3DDA OCA].
==Reference==
==Reference==
-
Substrate binding mode and its implication on drug design for botulinum neurotoxin A., Kumaran D, Rawat R, Ahmed SA, Swaminathan S, PLoS Pathog. 2008 Sep 26;4(9):e1000165. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18818739 18818739]
+
<ref group="xtra">PMID:18818739</ref><references group="xtra"/>
[[Category: Bontoxilysin]]
[[Category: Bontoxilysin]]
[[Category: Clostridium botulinum]]
[[Category: Clostridium botulinum]]
-
[[Category: Protein complex]]
+
[[Category: Kumaran, D.]]
-
[[Category: Pdbx_ordinal=, <PDBx:audit_author.]]
+
[[Category: Swaminathan, S.]]
[[Category: Alternative splicing]]
[[Category: Alternative splicing]]
[[Category: Bio-warfare agent]]
[[Category: Bio-warfare agent]]
Line 52: Line 52:
[[Category: Zinc]]
[[Category: Zinc]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 24 20:23:06 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 08:37:49 2009''

Revision as of 06:37, 18 February 2009

Image:3dda.png

Template:STRUCTURE 3dda

Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide

Template:ABSTRACT PUBMED 18818739

About this Structure

3DDA is a 2 chains structure of sequences from Clostridium botulinum. Full crystallographic information is available from OCA.

Reference

  • Kumaran D, Rawat R, Ahmed SA, Swaminathan S. Substrate binding mode and its implication on drug design for botulinum neurotoxin A. PLoS Pathog. 2008 Sep 26;4(9):e1000165. PMID:18818739 doi:10.1371/journal.ppat.1000165

Page seeded by OCA on Wed Feb 18 08:37:49 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3dda"
Personal tools